We also observed no overall survival differences according to the SLC4A7 mRNA expression level across the whole unstratified population of breast cancer patients (Figure 10B) where the survival effects of differences in SLC4A7 transcript levels within specific molecular subgroups are diluted in the larger patient population. Here, SLC4A7 is linked to breast carcinoma.